1. Home
  2. ORMP vs ADAG Comparison

ORMP vs ADAG Comparison

Compare ORMP & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORMP
  • ADAG
  • Stock Information
  • Founded
  • ORMP 2002
  • ADAG 2011
  • Country
  • ORMP United States
  • ADAG China
  • Employees
  • ORMP N/A
  • ADAG N/A
  • Industry
  • ORMP Biotechnology: Pharmaceutical Preparations
  • ADAG Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORMP Health Care
  • ADAG Health Care
  • Exchange
  • ORMP Nasdaq
  • ADAG Nasdaq
  • Market Cap
  • ORMP 90.7M
  • ADAG 81.9M
  • IPO Year
  • ORMP N/A
  • ADAG 2021
  • Fundamental
  • Price
  • ORMP $2.45
  • ADAG $1.81
  • Analyst Decision
  • ORMP Hold
  • ADAG Strong Buy
  • Analyst Count
  • ORMP 1
  • ADAG 1
  • Target Price
  • ORMP N/A
  • ADAG $8.00
  • AVG Volume (30 Days)
  • ORMP 478.1K
  • ADAG 149.2K
  • Earning Date
  • ORMP 03-05-2025
  • ADAG 03-09-2025
  • Dividend Yield
  • ORMP N/A
  • ADAG N/A
  • EPS Growth
  • ORMP N/A
  • ADAG N/A
  • EPS
  • ORMP 0.11
  • ADAG N/A
  • Revenue
  • ORMP N/A
  • ADAG $815,746.00
  • Revenue This Year
  • ORMP N/A
  • ADAG N/A
  • Revenue Next Year
  • ORMP N/A
  • ADAG $2.70
  • P/E Ratio
  • ORMP $22.15
  • ADAG N/A
  • Revenue Growth
  • ORMP N/A
  • ADAG N/A
  • 52 Week Low
  • ORMP $2.00
  • ADAG $1.64
  • 52 Week High
  • ORMP $3.67
  • ADAG $3.66
  • Technical
  • Relative Strength Index (RSI)
  • ORMP 58.75
  • ADAG 45.96
  • Support Level
  • ORMP $2.16
  • ADAG $1.68
  • Resistance Level
  • ORMP $3.09
  • ADAG $1.95
  • Average True Range (ATR)
  • ORMP 0.15
  • ADAG 0.12
  • MACD
  • ORMP 0.03
  • ADAG 0.00
  • Stochastic Oscillator
  • ORMP 34.02
  • ADAG 35.42

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

About ADAG Adagene Inc.

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: